Dexamethasone
Brand names: Dexsol, Martapan
Dexamethasone is a potent long-acting corticosteroid used systemically in ENT practice for indications such as severe airway or laryngeal oedema, control of postoperative swelling and nausea, and as an adjunct in some inflammatory and oncological settings.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a glucocorticoid with potent anti-inflammatory and immunosuppressant actions and minimal mineralocorticoid effect, reducing inflammatory mediator production and tissue oedema.
Prescribing in practice
- Corticosteroids should not be stopped abruptly after more than a short course because of the risk of adrenal insufficiency, and patients on prolonged therapy need a steroid treatment card and gradual withdrawal.
- It can cause hyperglycaemia, mood and sleep disturbance, increased infection risk and gastrointestinal effects, so use cautiously in diabetes, active infection and peptic ulcer disease.
- Even short courses may unmask or worsen infection, so exclude untreated systemic infection before use.
Monitoring
For more than brief use, monitor blood glucose, blood pressure, mood and signs of infection, and review the need for continued treatment.
Counselling the patient
- Do not stop suddenly if you have taken it for more than a few days.
- Tell other healthcare professionals you are taking a steroid, and carry a steroid card if on a longer course.
- Report signs of infection, marked mood change or high blood sugars.
Evidence & guidelines
Systemic corticosteroids such as dexamethasone are established for reducing airway oedema and perioperative swelling, with use guided by standard corticosteroid prescribing principles.
Reference: NICE NG205 (SSNHL 2023); NICE CKS Croup; Cochrane (Steward et al. 2011) Dexamethasone post-tonsillectomy; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020